Mach7 Technologies Ltd. (TDMMF)
OTHER OTC:TDMMF
Want to see TDMMF full AI Analyst Report?
TDMMF Stock Chart & Stats
$0.29
$0.00(0.00%)
At close: 4:00 PM EST
$0.29
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.24 - $0.50
Previous CloseN/A
Volume72.00
Average Volume (3M)528.00
Market Cap
$46.89M
Enterprise Value$47.89M
Total Cash (Recent Filing)$18.49M
Total Debt (Recent Filing)$1.75M
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding235,009,720
10 Day Avg. Volume0
30 Day Avg. Volume528
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)1.74
Price to Sales (P/S)2.35
P/FCF Ratio701.76
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue1.61
Enterprise Value/Gross Profit31.20
Enterprise Value/Ebitda-7.39
Forecast
1Y Price Target
$0.32Price Target Upside10.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$23.97M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthA 75.5% surge in revenue in the latest year signals expanding commercial traction and market adoption of Mach7's imaging software. Durable top-line growth increases scale, supports recurring contract expansion and provides a larger base for margin improvement and reinvestment over the next 2–6 months.
Conservative Balance SheetA low debt-to-equity profile and healthy equity ratio provide financial flexibility to fund product development, sales expansion or absorb short-term shocks without heavy refinancing. This capital structure supports sustained investment in go-to-market execution and optionality over time.
Enterprise Imaging NicheSpecialization in enterprise medical imaging and integration into hospital systems targets a structural digitization trend in healthcare. Deep integration into clinical workflows creates higher switching costs and sticky revenue potential from long-term contracts and platform adoption.
Bears Say
Weak ProfitabilityPersistently negative net profit and EBIT margins indicate the business still faces operational cost and pricing pressures. Until margins turn positive, the company will struggle to sustainably fund growth and generate shareholder returns without improving unit economics or reducing operating leverage.
Volatile Cash GenerationA recent sharp decline in free cash flow growth and a low operating-cash-to-net-income ratio show inconsistent cash conversion. Volatility in cash generation raises reliance on external funding for capex or sales investments and increases execution risk over the medium term.
Sharp EPS ContractionA near-100% drop in EPS signals material earnings deterioration and recent losses. This level of EPS contraction reduces internal funding capacity, complicates planning for margin recovery and makes multi-quarter operational progress necessary before profitability is durable.
Mach7 Technologies News
TDMMF FAQ
What was Mach7 Technologies Ltd.’s price range in the past 12 months?
Mach7 Technologies Ltd. lowest stock price was $0.24 and its highest was $0.50 in the past 12 months.
What is Mach7 Technologies Ltd.’s market cap?
Mach7 Technologies Ltd.’s market cap is $46.89M.
When is Mach7 Technologies Ltd.’s upcoming earnings report date?
Mach7 Technologies Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 115 days.
How were Mach7 Technologies Ltd.’s earnings last quarter?
Mach7 Technologies Ltd. released its earnings results on Feb 26, 2026. The company reported -$0.017 earnings per share for the quarter, missing the consensus estimate of -$0.004 by -$0.014.
Is Mach7 Technologies Ltd. overvalued?
According to Wall Street analysts Mach7 Technologies Ltd.’s price is currently Undervalued.
Does Mach7 Technologies Ltd. pay dividends?
Mach7 Technologies Ltd. does not currently pay dividends.
What is Mach7 Technologies Ltd.’s EPS estimate?
Mach7 Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mach7 Technologies Ltd. have?
Mach7 Technologies Ltd. has 235,009,720 shares outstanding.
What happened to Mach7 Technologies Ltd.’s price movement after its last earnings report?
Mach7 Technologies Ltd. reported an EPS of -$0.017 in its last earnings report, missing expectations of -$0.004. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Mach7 Technologies Ltd.?
Currently, no hedge funds are holding shares in TDMMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mach7 Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.32 (10.05% Upside)
$0.32 (10.05% Upside)
Blogger Sentiment
Bullish
TDMMF Sentiment 70%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $133.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.50%
12-Months-Change
Fundamentals
Return on Equity
-23.86%
Trailing 12-Months
Asset Growth
-19.47%
Trailing 12-Months
Company Description
Mach7 Technologies Ltd.
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing solutions that include eUnity enterprise viewer, eUnity diagnostic viewer, and simplify image access. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.
TDMMF Company Deck
TDMMF Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated a constructive operational pivot: management presented a clear strategic reset, measurable cost reductions (payments down 9% YoY, 6% QoQ), stronger cash flow (positive operating cash flow in Q2), a stable ARR run rate of $23M, and early commercial/product milestones (first Flamingo customer, CE certificate). These positives are tempered by a near-term reduction in CARR of $2.9M (removal of the NTP project), the strategic exit from the VHA program that reduced backlog but improves long-term margin prospects, lingering VNA/KLAS performance work that may take 12–24 months to fully resolve, and a CTO search following the CIO departure. Overall, the highlights (stabilized ARR, improved cash and cost discipline, new product momentum and regulatory/market expansion) outweigh the lowlights, although several improvements will take time to flow through revenue.View all TDMMF earnings summariesTDMMF Stock 12 Month Forecast
Average Price Target
$0.32
▲(10.05% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Pro Medicus Limited
―
Beamtree Holdings Ltd
―
Artrya Limited
―
Alcidion Group Limited
―
Ownership Overview
Options Prices
Currently, No data available
---